Kawin Technology Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Public

  • Employees
  • 584

Employees

  • Stock Symbol
  • 688687

Stock Symbol

  • Investments
  • 2

  • Share Price
  • $3.72
  • (As of Wednesday Closing)

Kawin Technology General Information

Description

Beijing Kawin Technology Share-Holding Co Ltd is a biotechnology company. It offers healthcare solutions for liver disease. The company's products include Pirfenidone Tablets, Peginterferon Alfacon-2 Injection, and Compound glycyrrhizin capsules.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Stock Exchange
SHG
Corporate Office
  • No. 6 Rongjing Street East
  • Beijing Economic and Technological Development Zone
  • Beijing, 100176
  • China
+86 010 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kawin Technology Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.72 $3.80 $2.54 - $5.26 $636M 171M 3.98M $0.10

Kawin Technology Financials Summary

In Thousands,
USD
TTM 31-Mar-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 611,497 687,787 390,951 540,313
Revenue 200,256 199,580 172,242 177,225
EBITDA 18,215 23,831 17,576 21,412
Net Income 16,436 16,470 12,385 16,616
Total Assets 340,556 345,373 320,282 341,654
Total Debt 15,171 7,748 2,264 536
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Kawin Technology Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Kawin Technology‘s full profile, request access.

Request a free trial

Kawin Technology Patents

Kawin Technology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4180456-A1 Antibody binding to hepatitis b virus surface antigen and application of antibody Pending 09-Jul-2020 00000000
US-20230265168-A1 Antibody binding to hepatitis b virus surface antigen and application of antibody Pending 09-Jul-2020 0000000000
EP-4180456-A4 Antibody binding to hepatitis b virus surface antigen and application of antibody Pending 09-Jul-2020 C07K16/082 0

Kawin Technology Executive Team (2)

Name Title Board Seat Contact Info
Desheng Zhou MD Chairman & General Manager
Yunde Hou Founder
To view Kawin Technology’s complete executive team members history, request access »

Kawin Technology Board Members (6)

Name Representing Role Since
Desheng Zhou MD Kawin Technology Chairman & General Manager 000 0000
Hui Li Self Board Member 000 0000
Liping Zhang Self Board Member 000 0000
Ningning Ma Self Board Member 000 0000
Qingmin Wu Self Co-Chairman 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Kawin Technology Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kawin Technology Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Kawin Technology‘s full profile, request access.

Request a free trial

Kawin Technology Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Sciwind Biosciences 11-Jan-2019 00000 0000 000.00 Biotechnology
Ginkgo 03-Aug-2015 Corporate Drug Discovery
To view Kawin Technology’s complete investments history, request access »

Kawin Technology FAQs

  • When was Kawin Technology founded?

    Kawin Technology was founded in 2008.

  • Who is the founder of Kawin Technology?

    Yunde Hou is the founder of Kawin Technology.

  • Where is Kawin Technology headquartered?

    Kawin Technology is headquartered in Beijing, China.

  • What is the size of Kawin Technology?

    Kawin Technology has 584 total employees.

  • What industry is Kawin Technology in?

    Kawin Technology’s primary industry is Pharmaceuticals.

  • Is Kawin Technology a private or public company?

    Kawin Technology is a Public company.

  • What is Kawin Technology’s stock symbol?

    The ticker symbol for Kawin Technology is 688687.

  • What is the current stock price of Kawin Technology?

    As of 19-Jun-2024 the stock price of Kawin Technology is $3.72.

  • What is the current market cap of Kawin Technology?

    The current market capitalization of Kawin Technology is $636M.

  • What is Kawin Technology’s current revenue?

    The trailing twelve month revenue for Kawin Technology is $200M.

  • What is Kawin Technology’s annual earnings per share (EPS)?

    Kawin Technology’s EPS for 12 months was $0.10.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »